Targeted delivery combined with controlled drug release has a pivotal role in the future of
personalized medicine. This review covers the principles, advantages, and drawbacks of …

Nanomaterials are increasingly used as drug carriers for cancer therapy. Nanomaterials
also appeal to researchers in the areas of cancer diagnosis and biomarker discovery …

During the last two decades, an increasing number of reports have pointed out that the
immunogenicity of polyethylene glycol (PEG) may trigger accelerated blood clearance …

Although nanomedicine has been highly investigated for cancer treatment over the past
decades, only a few nanomedicines are currently approved and in the market; making this …

The rapid development of nanotechnology provides alternative approaches to overcome
several limitations of conventional anti-cancer therapy. Drug targeting using functionalized …

Cancer is a life-threatening disease killing millions of people globally. Among various
medical treatments, nano-medicines are gaining importance continuously. Many …

The treatment of malignancies has undergone dramatic changes in the past few decades.
Advances in drug delivery techniques and nanotechnology have allowed for new …

Tumor-promoting inflammation is accompanied by cancer initiation, progression, and
metastasis. Cyclooxygenase-2 (COX-2) and its downstream product, prostaglandin E2 …

Intraperitoneal (IP) drug delivery represents an attractive strategy for the local treatment of
peritoneal carcinomatosis (PC). Over the past decade, a lot of effort has been put both in the …

Intraperitoneal (IP) chemotherapy has revived hopes during the past few years for the
management of peritoneal disseminations of digestive and gynecological cancers …